New Zealand markets open in 9 hours 14 minutes

10x Genomics, Inc. (TXG)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
22.37-0.18 (-0.80%)
At close: 04:00PM EDT
22.37 0.00 (0.00%)
Pre-market: 08:00AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.70B
Enterprise value 2.40B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)4.21
Price/book (mrq)3.72
Enterprise value/revenue 3.81
Enterprise value/EBITDA -40.69

Trading information

Stock price history

Beta (5Y monthly) 1.85
52-week change 3-51.57%
S&P500 52-week change 326.33%
52-week high 357.90
52-week low 315.28
50-day moving average 320.44
200-day moving average 332.89

Share statistics

Avg vol (3-month) 31.84M
Avg vol (10-day) 31.29M
Shares outstanding 5106.44M
Implied shares outstanding 6121.49M
Float 8104.4M
% held by insiders 12.18%
% held by institutions 197.17%
Shares short (30 Aug 2024) 48.94M
Short ratio (30 Aug 2024) 45.43
Short % of float (30 Aug 2024) 49.73%
Short % of shares outstanding (30 Aug 2024) 47.42%
Shares short (prior month 31 Jul 2024) 411.12M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 Jun 2024

Profitability

Profit margin -37.96%
Operating margin (ttm)-27.26%

Management effectiveness

Return on assets (ttm)-11.95%
Return on equity (ttm)-31.60%

Income statement

Revenue (ttm)631.73M
Revenue per share (ttm)5.32
Quarterly revenue growth (yoy)4.30%
Gross profit (ttm)N/A
EBITDA -146.28M
Net income avi to common (ttm)-239.78M
Diluted EPS (ttm)-2.03
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)380.09M
Total cash per share (mrq)3.15
Total debt (mrq)89.48M
Total debt/equity (mrq)12.36%
Current ratio (mrq)5.22
Book value per share (mrq)6.01

Cash flow statement

Operating cash flow (ttm)-7.78M
Levered free cash flow (ttm)62.79M